Minimally Invasive Surgery Devices Market Size, Share, Growth and Forecast, 2025-2035

Smaller incisions move more surgery to outpatient care

The global minimally invasive surgery devices market was valued at USD 32.85 billion in 2025 and is projected to increase from USD 34.81 billion in 2026 to USD 58.63 billion by 2035, registering a CAGR of 5.96% during 2026–2035. Demand comes from hospitals, ambulatory surgical centers and clinics that replace open procedures with small-incision, catheter-based and endoscopic approaches, because patients recover faster and leave the hospital sooner. North America held the largest regional share, 40.0% in 2025, as high procedure volumes, broad insurance coverage and early adoption of surgical robots support spending. Asia Pacific is the fastest-growing region at 7.22% a year, as China, India and Southeast Asian countries add operating rooms and train more laparoscopic surgeons. The main change is wider competition in robotic platforms, with new systems from established device makers reaching U.S. hospitals in 2024 and 2025.

Which products and procedures count toward market value?

The market counts manufacturer revenue from instruments, energy systems, scopes, visualization equipment, ablation and laser systems and robotic platforms used to operate through small incisions or natural openings. It covers cardiovascular, gastrointestinal, gynecological, orthopedic, urological, neurological and aesthetic procedures. Buyers include hospitals, ambulatory surgical centers and specialty clinics that purchase capital equipment and recurring disposables.

Single-use and reusable instruments account for a steady flow of revenue, because each procedure consumes trocars, staplers, energy tips or catheters. The scope excludes open surgical instruments, implants sold on their own and hospital service fees, and the value chain runs from component suppliers and device makers through distributors to surgical teams.

Handheld tools, cardiac care and hospitals lead spending

Why do handheld instruments lead while robots grow fastest?

Based on product, the market is categorized into handheld instruments, guiding devices, electrosurgical devices, endoscopic devices, laparoscopic devices, monitoring and visualization devices, ablation devices, laser-based devices, robotic-assisted surgical systems and others. Handheld Instruments led with a 15.0% share of 2025 value, because graspers, dissectors and trocars are used in nearly every procedure. Robotic-assisted Surgical Systems grow fastest at 8.97% a year, as hospitals add consoles and buy instruments for each robotic case.

Why do cardiovascular procedures lead application spending?

Based on application, the market is categorized into aesthetic, cardiovascular, gastrointestinal, gynecological, orthopedic, urological, neurological and other applications. Cardiovascular procedures led with a 24.0% share of 2025 value, because catheter ablation, valve repair and vascular interventions use costly single-use systems. Urological procedures grow fastest at 7.33% a year, as robotic prostatectomy, nephrectomy and cystectomy spread to more hospitals.

Where are these procedures performed?

Based on end user, the market is categorized into hospitals, ASCs, clinics and others. Hospitals led with a 62.0% share of 2025 value, because complex cardiac, cancer and robotic cases need full operating suites and inpatient beds. ASCs grow fastest at 7.63% a year, as payers move more orthopedic, gastrointestinal and urological procedures to lower-cost outpatient settings.

Faster recovery, aging patients and new robotic systems

How does faster recovery shift surgeons away from open procedures?

Small-incision procedures usually cause less blood loss, less pain and shorter hospital stays than open surgery, which lowers the total cost of care for hospitals and payers. Patients also return to work sooner, so they increasingly ask for these options when they compare surgeons. As a result, laparoscopic and endoscopic techniques have become the standard approach for gallbladder removal, hernia repair and many colorectal and gynecological operations. This preference keeps instrument demand rising in both mature and emerging health systems, because each of these operations uses several access ports and a set of single-use tools.

Why does an aging population raise procedure volumes?

Older adults need more cardiac, orthopedic, urological and cancer procedures, and they benefit most from approaches that shorten recovery. World Bank data show that people aged 65 and over made up about 29.8% of Japan's population and 17.9% of the U.S. population in 2024. Because older patients often carry several chronic conditions, surgeons favor techniques that reduce trauma and complications. In turn, hospitals in aging countries such as Japan, where the share is 1.7 times the U.S. level, keep expanding capacity for catheter-based and laparoscopic care.

Download Free Sample

How do new robotic systems widen access to robotic surgery?

Hospitals now have more choice in surgical robots, which supports wider adoption and stronger price competition. In March 2024, Intuitive announced FDA 510(k) clearance for its fifth-generation da Vinci 5 system, which adds optional force feedback instruments. Medtronic then received FDA clearance for its Hugo system for urologic procedures in December 2025. As a result, more hospitals can evaluate surgical robotics programs from several suppliers through 2035.

Why does catheter-based ablation lift cardiovascular spending?

Cardiologists increasingly treat atrial fibrillation through catheters instead of open surgery, which raises demand for mapping systems and single-use ablation catheters. Boston Scientific received FDA approval for its FARAPULSE pulsed field ablation system in January 2024 for drug-refractory paroxysmal atrial fibrillation. Because pulsed field energy targets heart tissue while sparing nearby structures, electrophysiology labs have adopted it quickly. This shift keeps cardiovascular procedures the largest application through 2035.

Robotics, pulsed field ablation and outpatient shifts

Why is competition in surgical robots rising?

The robotic segment is shifting from a near single-supplier field toward several competing platforms, which gives hospitals more negotiating power. Medtronic said its Hugo system is now cleared for prostatectomy, nephrectomy and cystectomy, procedures that account for about 230,000 surgeries a year in the U.S. Johnson & Johnson MedTech completed the first clinical cases with its Ottava system in April 2025 under an FDA investigational device exemption. This rise in choice should lower entry costs for mid-sized hospitals.

How are outpatient centers changing device demand?

Payers and surgeons are moving more joint, spine, hernia and endoscopic procedures from hospitals into ambulatory surgical centers, because outpatient care costs less and frees inpatient beds. These centers prefer compact towers, single-use instruments and fast-turnover energy systems that suit high daily case volumes. As a result, suppliers now design smaller electrosurgical generators and visualization stacks for outpatient rooms. This shift gives ASCs the fastest growth among end users.

Download Free Sample

Where is the opening in catheter-based vascular care?

Venous and arterial clot removal without drugs is a clear opening, because many patients with blood clots still receive only medication. Stryker completed its acquisition of Inari Medical in February 2025, adding mechanical thrombectomy systems for venous thromboembolism. Because these devices remove clots through small punctures, they suit interventional suites and short hospital stays. Companies with catheter platforms and trained field teams can capture this growth as clinical evidence builds.

Can emerging markets open room for value-priced systems?

Hospitals in India, Southeast Asia, Latin America and Africa want small-incision surgery but cannot always fund premium robots and towers. This gap creates an opening for reusable instruments, refurbished scopes and value-priced robotic platforms with lower per-case costs. Suppliers that pair equipment with surgeon training and local service networks can win public tenders. In turn, wider training programs expand the pool of surgeons who can perform these procedures.

Capital cost, training gaps and quality compliance

How does capital cost slow robot adoption?

Surgical robots require large upfront payments, service contracts and dedicated instruments, which strains budgets at smaller and public hospitals. Many health systems must show higher case volumes before they can justify a second or third console. As a result, adoption remains concentrated in large urban hospitals in North America, Western Europe and East Asia. Suppliers respond with leasing, per-procedure pricing and refurbished systems, although these options still require steady case loads.

Why do training gaps limit procedure growth?

Small-incision and robotic techniques have long learning curves, which means surgeons need simulation time, proctored cases and regular practice to stay proficient. Training capacity is limited in many countries, especially outside large teaching hospitals. These gaps slow the spread of advanced procedures to regional hospitals. In turn, device makers invest in simulators and training centers, although this adds cost to every new platform launch.

How do quality problems disrupt supply?

Manufacturing and reprocessing failures can halt shipments and force hospitals to change suppliers at short notice. In October 2026, the FDA announced an import alert for certain Olympus devices made in Japan, including some ureterorenoscopes, bronchoscopes, laparoscopes and enteroscopes. Because the alert stops future shipments of listed models, buyers must plan replacements and check reprocessing steps. This case shows how quality compliance now shapes purchasing decisions at many hospitals.

Why does reprocessing and infection risk weigh on reusable scopes?

Reusable scopes have narrow channels that are hard to clean, which raises infection concerns when reprocessing steps are missed. Hospitals must invest in staff training, automated reprocessors and tracking systems to meet cleaning standards. This burden pushes some buyers toward single-use endoscopes for selected procedures. However, disposable scopes raise per-case costs and medical waste, so most hospitals still use a mix of both.

U.S. hospitals lead as Asian surgical capacity grows

North America leads on robotic installed base

North America held a 40.0% share of 2025 value and grows at 5.52% a year through 2035. The U.S. leads spending, because hospitals run large numbers of robotic, cardiac and laparoscopic procedures under broad insurance coverage. New robotic clearances in 2024 and 2025 widen supplier choice for U.S. hospitals. However, cost controls by payers push more cases into outpatient centers, which favors compact equipment. Medtronic estimates that about 230,000 prostatectomy, nephrectomy and cystectomy procedures take place each year in the U.S., a large base for robotic urology.

Europe balances tenders and outpatient growth

Europe held a 27.0% share of 2025 value and grows at 5.22% a year, the slowest pace among the five regions. Germany, France, Italy, Spain and the U.K. account for most demand, with public hospital groups buying through competitive tenders. As a result, suppliers compete on price per procedure, while day-case surgery programs lift demand for compact laparoscopic towers. Germany also has one of the oldest populations in the region, with 23.2% of residents aged 65 and over in 2024.

Download Free Sample

Asia Pacific grows on new operating rooms

Asia Pacific held a 24.0% share of 2025 value and is the fastest-growing region at 7.22% a year. China and India are adding hospitals and training more laparoscopic surgeons, while Japan and South Korea have high robotic adoption. Local manufacturers in China compete on price for instruments and robots. In turn, global suppliers focus on premium platforms and training partnerships. China had 14.7% of its population aged 65 and over in 2024, which points to rising cardiac, orthopedic and cancer surgery demand.

Latin America relies on private hospital groups

Latin America held a 5.0% share of 2025 value and grows at 6.42% a year through 2035. Brazil and Mexico account for most demand, where private hospital groups buy robots and towers for urban centers. Currency swings and public budget limits slow equipment purchases in many countries.

Middle East and Africa invest in flagship hospitals

The Middle East & Africa held a 4.0% share of 2025 value and grows at 6.62% a year. Gulf states invest in robotic programs at flagship public and private hospitals. In much of Africa, limited surgeon training and equipment budgets keep adoption low outside large cities.

Download Free Sample

Robotic clearances and device deals from 2024 to 2026

Force feedback and better imaging raise precision

• Force feedback instruments on the da Vinci 5 let surgeons sense tissue pressure, and preclinical tests showed up to 43% less force on tissue.
• Pulsed field ablation uses short electrical pulses to isolate heart tissue through ablation catheters with less heat damage.
• Modular robotic arms such as those on the Hugo system can be positioned around the patient to suit different operating rooms.
• High-definition and 3D visualization give surgeons clearer views of anatomy through small ports and natural openings.
• Mechanical thrombectomy catheters remove blood clots from veins without the use of clot-dissolving drugs.

Robot makers and instrument suppliers fight for share

Competition in minimally invasive surgery devices rests on installed robotic and visualization systems, broad instrument portfolios and surgeon training. Intuitive Surgical leads robotic surgery with a large installed base of da Vinci systems, while Medtronic and Johnson & Johnson (Ethicon) compete with new robots, staplers and energy devices. Boston Scientific focuses on catheter-based cardiology, urology and endoscopy, and Stryker builds on orthopedic robotics and vascular devices. Olympus and HOYA Corporation supply flexible and rigid scopes, while Koninklijke Philips N.V. offers image-guided therapy systems. Zimmer Biomet, Smith & Nephew and CONMED compete in orthopedic and arthroscopic tools, and Renishaw supplies neurosurgical robotics. Because hospitals rarely switch platforms, suppliers win share through new systems, training and acquisitions.

Companies profiled and their roles in this market

Robotics and outpatient care set the growth pace

Credence Research's view is that robotics and outpatient care will set the growth pace for minimally invasive surgery devices through 2035. Handheld instruments keep the largest share because every procedure consumes them, but robotic systems add value faster as more suppliers win clearances and hospitals add consoles. Catheter-based ablation and clot removal widen the role of small-incision care in cardiology and vascular medicine. Quality compliance remains a key risk, as the 2026 Olympus import alert shows. Suppliers with broad portfolios and strong training programs are best placed to grow.

Procedure volumes and device prices anchor the model

The report uses 2025 as the base year and forecasts market value to 2035, with growth rates stated for 2026–2035. Market values come from the Credence Research market model, which combines procedure volumes by application, installed systems and average device prices by region and end user. Splits by product, application, end user and region are Credence Research estimates. Sources used include FDA notices, SEC filings, World Bank population data and company press releases. No primary interviews or surveys were used to build the estimates in this report.

Robotic and catheter-based care gain share by 2035

By 2035, the market reaches USD 58.63 billion, with handheld instruments still providing the largest share of product value. Robotic systems gain share as competing platforms reach more hospitals, and urological procedures grow fastest among applications. ASCs take a larger share of cases as payers push lower-cost settings. Asia Pacific adds capacity as China and India build operating rooms, while North America remains the largest region. Suppliers keep investing in training, imaging and catheter platforms to defend their positions.

Note: The depth of individual sections depends on data availability for this market. Volume, capacity, trade and other unit-based metrics are included where applicable.